Structures of DSHNHL
Managing committee of DSHNHL
| Prof. Dr. M. Pfreundschuh | Homburg /Saar |
| Prof. Dr. N. Schmitz | Hamburg |
| Prof. Dr. L. Truemper | Goettingen |
| Prof. Dr. M. Loeffler | Leipzig |
Leading commission
| Prof. Dr. M. Pfreundschuh Dr. G. Held |
Saarland University Hospital Central Office DSHNHL Internal Medicine I, Geb. 40 66421 Homburg/Saar |
Tel.: +49 (0) 6841 16-23084 Fax: +49 (0) 6841 16-23004 dshnhl@uniklinikum-saarland.de |
| Prof. Dr. N. Schmitz Prof. Dr. B. Glass Dr. M. Nickelsen |
Asklepios Hospital St. Georg Lohmuehlenstr. 5 20099 Hamburg |
Tel.: +49 (0) 40 18 18 85-2005 Fax: +49 (0) 40 18 18 85-4226 E-Mail-Adresse E-Mail-Adresse |
| Prof. Dr. L. Truemper Prof. Dr. G. Wulf Dr. J. Hasenkamp |
Georg-August-University Centre for Internal Medicine Department of Haematology & Onkology Robert-Koch-Str. 40 37075 Goettingen |
Tel.: +49 (0) 551 39-8535 Fax.:+49 (0) 551 39-8587 E-Mail-Adresse E-Mail-Adresse E-Mail-Adresse |
| Prof. Dr. M. Loeffler Dipl.-Math. M. Ziepert |
Institute for Medical Informatics, Statistics und Epidemiology, University of Leipzig (IMISE) Haertelstr. 16-18 04107 Leipzig |
Tel.: +49 (0) 341 97-16100 Fax: +49 (0) 341 97-16109 E-Mail-Adresse |
Beside the central office in Homburg, biometry in Leipzig (IMISE) as well as the clinical competence centres in Hamburg (St. Georg Hospital) and at the University of Goettingen, we also have a close collaboration with the (german) reference panel of lymphoma pathologists and the reference centre for radiotherapy in Homburg for a rapid and competent consultation of participating physicians and assistance calling patients as also for an efficient realization of studies on a high quality level.
Structures for quality assurance
The DSHNHL (German High Grade Non-Hodgkin's Lymphoma Study Group) established significant structures of quality assurance: A reference pathology (guidance: Prof. Dr. A. Feller, Luebeck) as soon as reference radiotherapy (guidance: Prof. Dr. C. Ruebe) were organized. Time-fairly insertion of these reference centres will guarantee patients a secondary investigation of their diagnosis up to 10% of the first diagnosis will be corrected by the reference pathology - and that in case of a radiotherapy they will get a treatment on highest international standards.
Navigation
Clinical Trials & Study Groups
Foerderer, Partner und Zertifikate
,
